Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

NCT02502396 · clinicaltrials.gov ↗
COMPLETED
Status
265
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators